EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sustainable Design and DoE-Based Optimization of Polymeric Systems for FDM 3D-Printed Indomethacin Amorphous Solid Dispersions

Ioannis Pantazos iD, Christos Cholevas iD, Christos Vlachokostas iD, Afroditi Kapourani iD, Panagiotis Barmpalexis iD

Pharmaceuticals · 01.04.2026 · 19 (4) · 562

DOI: 10.3390/ph19040562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 01.04.2026. Verfasst von Ioannis Pantazos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Technology, Division of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences, Aristotle University …. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "SUB1.1: Clusters of Research Excellence (CREs)" by the European Union - Next Generation EU - National Recovery and Resilience Plan (NRRP) - Greece 2.0, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Amorphous solid dispersions (ASDs) produced via hot-melt extrusion (HME) and fused deposition modeling (FDM) 3D printing represent a promising strategy for improving the performance of poorly water-soluble drugs. However, the integrated HME-FDM workflow is inherently energy-intensive, and sustainability considerations are rarely incorporated into formulation and process optimization. The present study aimed to develop and optimize indomethacin (IND) ASDs using a systematic Design of Experiment (DoE) framework that integrates electrical energy consumption as a quantitative response alongside pharmaceutical performance attributes.

Methods

Polymer–plasticizer miscibility was screened using hot-stage microscopy, followed by filament preparation via HME. A factorial DoE was applied to optimize drug loading and extrusion temperature considering electrical energy consumption, extrusion yield, encapsulation efficiency, and residual crystallinity. Solid-state characterization was performed using DSC and XRD. The optimized filament was subsequently subjected to geometry screening and a second DoE to optimize platform temperature, nozzle temperature, and printing speed with respect to printing time, electrical energy consumption, and drug assay.

Results

Complete drug amorphization was achieved within a defined thermal window, with residual crystallinity governed by kinetic dissolution constraints at lower extrusion temperatures. Electrical energy demand during both HME and FDM was strongly influenced by thermal setpoints and process duration. Multi-response overlay analysis identified sustainability-oriented operating windows for both stages. Experimental validation confirmed close agreement between predicted and observed responses, demonstrating simultaneous reduction in electrical demand and maintenance of dose accuracy and solid-state stability.

Conclusions

This study demonstrates that electrical energy consumption can be systematically embedded as a quantitative design variable in pharmaceutical process optimization. The proposed dual-stage DoE strategy establishes a rational framework for developing 3D-printed ASD dosage forms that balance molecular performance and environmental efficiency.

Schlagwörter

Stichwörter der Autor:innen

amorphous solid dispersionsdesign of experimentselectrical energy optimizationfused deposition modelinghot-melt extrusionsustainability-by-design

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Technology, Division of Pharmaceutical Technology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Sustainability Engineering Laboratory, Department of Mechanical Engineering, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Natural Products Research Centre of Excellence-AUTH (NatPro-AUTH), Center for Interdisciplinary Research and Innovation (CIRI-AUTH), 570 01 Thessaloniki, Greece.

ORCID-Profile: Ioannis Pantazos, Christos Cholevas, Christos Vlachokostas, Afroditi Kapourani, Panagiotis Barmpalexis

Förderung

  • "SUB1.1: Clusters of Research Excellence (CREs)" by the European Union - Next Generation EU - National Recovery and Resilience Plan (NRRP) - Greece 2.0
  • European Union

Zitieren

APA

Pantazos, I., Cholevas, C., Vlachokostas, C., Kapourani, A., & Barmpalexis, P. (2026). Sustainable Design and DoE-Based Optimization of Polymeric Systems for FDM 3D-Printed Indomethacin Amorphous Solid Dispersions. Pharmaceuticals, 19(4), 562. https://doi.org/10.3390/ph19040562

Vancouver

Pantazos I, Cholevas C, Vlachokostas C, Kapourani A, Barmpalexis P. Sustainable Design and DoE-Based Optimization of Polymeric Systems for FDM 3D-Printed Indomethacin Amorphous Solid Dispersions. Pharmaceuticals. 2026;19(4):562. doi:10.3390/ph19040562

BibTeX
@article{Pantazos2026,
  author = {Pantazos, Ioannis and Cholevas, Christos and Vlachokostas, Christos and Kapourani, Afroditi and Barmpalexis, Panagiotis},
  title = {Sustainable Design and DoE-Based Optimization of Polymeric Systems for FDM 3D-Printed Indomethacin Amorphous Solid Dispersions},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {4},
  pages = {562},
  doi = {10.3390/ph19040562}
}
Kostenlos starten →